Preshunt liver function remains the prominent determinant of survival after portasystemic shunting

被引:2
作者
Cowgill, Sarah M.
Carey, Elizabeth
Villadolid, Desiree
Al-Saadi, Sam
Zervos, Emmanuel E.
Rosemurgy, Alexander S.
机构
[1] Univ S Florida, Coll Med, Digest Disorders Ctr, Tampa Gen Hosp, Tampa, FL 33601 USA
[2] Univ S Florida, Coll Med, Dept Surg, Tampa, FL 33601 USA
关键词
portacaval shunts; portal hypertension; H-graft; child class; model for end-stage liver disease score;
D O I
10.1016/j.amjsurg.2006.08.007
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Forty-five years after the development of the Child classification, we sought to determine if hepatic function is still a primary determinant between short-term and long-term survival after porta-systemic shunting. Methods: One hundred forty-six patients underwent small-diameter prosthetic H-graft portacaval shunting (HGPCS). The patients were stratified into 2 groups: those surviving less than 5 years and those surviving more than 5 years. Preoperative data determined Child class and model for end-stage liver disease (MELD) score. Results: Ninety-four (64%) patients were short-term and 52 (36%) patients were long-term survivors. No significant differences in the cause of cirrhosis, presence of ascites, encephalopathy, or emergency operations were noted between short- and long-term survivors. Preshunt MELD scores were significantly greater with short-term survivors, although actual survival was superior to predicted survival by MELD. Child class was inferior for short-term survivors. Child class and MELD score significantly correlated with survival after portasystemic shunting. Conclusions: Long-term survival after HGPCS is possible even with severe hepatic dysfunction; however, actual survival is superior to predicted survival. Hepatic dysfunction, as denoted by Child class and MELD, still remains a primary determinant of survival after portasystemic shunting. (c) 2006 Excerpta Medica Inc. All rights reserved.
引用
收藏
页码:617 / 621
页数:5
相关论文
共 7 条
[1]  
Child CG TJ, 1964, SURG PORTAL HYPERTEN, P50
[2]   Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients - A case-control comparison [J].
Helton, WS ;
Maves, R ;
Wicks, K ;
Johansen, K .
ARCHIVES OF SURGERY, 2001, 136 (01) :17-20
[3]   H-graft portacaval shunts versus TIPS - Ten-year follow-up of a randomized trial with comparison to predicted survivals [J].
Rosemurgy, AS ;
Bloomston, M ;
Clark, WC ;
Thometz, DP ;
Zervos, EE .
ANNALS OF SURGERY, 2005, 241 (02) :238-246
[4]   Post-shunt resource consumption favors small-diameter prosthetic H-graft portacaval shunt over TIPS for patients with poor hepatic reserve [J].
Rosemurgy, AS ;
Zervos, EE ;
Bloomston, M ;
Durkin, AJ ;
Clark, WC ;
Goff, S .
ANNALS OF SURGERY, 2003, 237 (06) :820-827
[5]   Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: Extended follow-up of an expanded randomized prospective trial [J].
Rosemurgy, AS ;
Serafini, FM ;
Zweibel, BR ;
Black, TJ ;
Kudryk, BT ;
Nord, HJ ;
Goode, SE .
JOURNAL OF GASTROINTESTINAL SURGERY, 2000, 4 (06) :589-596
[6]  
ROSEMURGY AS, 2001, MASTERY SURG
[7]   Comparison of MELD, Child-Pugh, and emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting [J].
Schepke, M ;
Roth, F ;
Fimmers, R ;
Brensing, KA ;
Sudhop, T ;
Schild, HH ;
Sauerbruch, T .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (05) :1167-1174